Yan Huang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Prognostic Factors

Coronary Artery Bypass

Ejection Fraction

Top Venues

Journal of gynecologic oncology

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Chenlian Quan, Zhong Zheng, Siyu Cao, Yong Wu, Wei Zhang, Yan Huang
The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients. Journal of gynecologic oncology 35 (4) (2024)
Chenlian Quan, Zhong Zheng, Siyu Cao, Yong Wu, Wei Zhang, Yan Huang
The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients. Journal of gynecologic oncology 35 (4) (2024)
Chenlian Quan, Zhong Zheng, Siyu Cao, Yong Wu, Wei Zhang, Yan Huang
The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients. Journal of gynecologic oncology (2024)
Chenlian Quan, Zhong Zheng, Siyu Cao, Yong Wu, Wei Zhang, Yan Huang
The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients. Journal of gynecologic oncology 35 (4) (2024)
Chenlian Quan, Zhong Zheng, Siyu Cao, Yong Wu, Wei Zhang, Yan Huang
The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients. Journal of gynecologic oncology 35 (4) (2024)
Kankan Cao, Guodong Zhang, Moran Yang, Yiying Wang, Mengdi He, Chen Zhang, Yan Huang, Jiaqi Lu, Haiou Liu
Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer. Cancer research (2023)
Junjun Qiu, Shugen Sun, Qinqin Liu, Jie Fu, Yan Huang, Ke-Qin Hua
A comparison of concurrent chemoradiotherapy and radical surgery in patients with specific locally advanced cervical cancer (stage IB3, IIA2, IIICr): trial protocol for a randomized controlled study (C-CRAL trial). Journal of gynecologic oncology (2023)